Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEAT-Calci: Interventions for Calciphylaxis
NCT05018221Phase 3Recruiting
- Sponsor
- University of Sydney
- Start
- Aug 2021
- Primary completion
- Dec 2029
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 3 trial of phytomenadione, magnesium, sodium thiosulfate in calciphylaxis (CUA), sponsored by University of Sydney. Started Aug 2021; status: recruiting.
02
Drugs
phytomenadionemagnesiumsodium thiosulfate
03
Conditions
calciphylaxis (CUA)
Beyond the preview
Go deeper on NCT05018221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05018221.